Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

OX40 (CD134) expression in sentinel lymph nodes correlates with prognostic features of primary melanomas
MaryClare Sarff, David Edwards, Birat Dhungel, et al.
The American Journal of Surgery (2008) Vol. 195, Iss. 5, pp. 621-625
Closed Access | Times Cited: 20

Showing 20 citing articles:

Clinical targeting of the TNF and TNFR superfamilies
Michael Croft, Chris A. Benedict, Carl F. Ware
Nature Reviews Drug Discovery (2013) Vol. 12, Iss. 2, pp. 147-168
Open Access | Times Cited: 427
Rationale for anti-OX40 cancer immunotherapy
Sandrine Aspeslagh, Sophie Postel‐Vinay, Sylvie Rusakiewicz, et al.
European Journal of Cancer (2015) Vol. 52, pp. 50-66
Closed Access | Times Cited: 294
Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators
João Conniot, Anna Scomparin, Carina Peres, et al.
Nature Nanotechnology (2019) Vol. 14, Iss. 9, pp. 891-901
Closed Access | Times Cited: 198
Current concepts of metastasis in melanoma
Blazej Zbytek, J. Andrew Carlson, Jacqueline Granese, et al.
Expert Review of Dermatology (2008) Vol. 3, Iss. 5, pp. 569-585
Open Access | Times Cited: 230
Inflammation: A key process in skin tumorigenesis (Review)
Monica Neagu, Carolina Constantin, Constantin Căruntu, et al.
Oncology Letters (2018)
Open Access | Times Cited: 117
New pathways in immune stimulation: targeting OX40
Carolina Alves Costa Silva, Francesco Facchinetti, Bertrand Routy, et al.
ESMO Open (2020) Vol. 5, Iss. 1, pp. e000573-e000573
Open Access | Times Cited: 75
OX40+ Regulatory T Cells in Cutaneous Squamous Cell Carcinoma Suppress Effector T-Cell Responses and Associate with Metastatic Potential
Chester Lai, Suzannah August, Amel Albibas, et al.
Clinical Cancer Research (2016) Vol. 22, Iss. 16, pp. 4236-4248
Open Access | Times Cited: 72
Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking
Anna H. Turaj, Kerry L. Cox, Christine A. Penfold, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 40
Revealing the mechanisms and therapeutic potential of immune checkpoint proteins across diverse protein families
Yizhi Liu, Xinyan Jiang, Ruijuan Dong, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Immune-related biomarkers for diagnosis/prognosis and therapy monitoring of cutaneous melanoma
Monica Neagu, Carolina Constantin, Cristiana Tănase
Expert Review of Molecular Diagnostics (2010) Vol. 10, Iss. 7, pp. 897-919
Closed Access | Times Cited: 49
The Immune System—A Hidden Treasure for Biomarker Discovery in Cutaneous Melanoma
Monica Neagu
Advances in clinical chemistry (2012), pp. 89-140
Closed Access | Times Cited: 39
Inflammation markers in cutaneous melanoma - edgy biomarkers for prognosis
Monica Neagu, Carolina Constantin, Georgiana Roxana Dumitrascu, et al.
Discoveries (2015) Vol. 3, Iss. 1, pp. e38-e38
Open Access | Times Cited: 31
Identification of microenvironment related potential biomarkers of biochemical recurrence at 3 years after prostatectomy in prostate adenocarcinoma
Xiaoru Sun, Lu Wang, Hongkai Li, et al.
Aging (2021) Vol. 13, Iss. 12, pp. 16024-16042
Open Access | Times Cited: 18
OX40 agonists for cancer treatment: a patent review
Jorge Cebada, Martín Pérez-Santos, Cindy Bandala, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 31, Iss. 1, pp. 81-90
Closed Access | Times Cited: 17
FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells
Lucia Campos Carrascosa, Adriaan A. van Beek, Valeska de Ruiter, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000816-e000816
Open Access | Times Cited: 15
Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients
Kimberley L. Kaufman, Swetlana Mactier, Nicola J. Armstrong, et al.
Clinical & Experimental Metastasis (2014) Vol. 31, Iss. 4, pp. 407-421
Open Access | Times Cited: 9
Concomitant Increase of OX40 and FOXP3 transcripts in peripheral blood of patients with breast cancer.
Maryam Hamidinia, Mehri Ghafourian, Abdolhassan Talaiezadeh, et al.
PubMed (2013) Vol. 10, Iss. 1, pp. 22-30
Closed Access | Times Cited: 8
Engaging stimulatory immune checkpoint interactions in the tumour immune microenvironment of primary liver cancers – how to push the gas after having released the brake
Yannick S. Rakké, Sonja I. Buschow, Jan N.M. IJzermans, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Melanocytic Neoplasms II: Molecular Staging
Michael J. Murphy, J. Andrew Carlson
Humana Press eBooks (2011), pp. 105-130
Closed Access | Times Cited: 2
Development of a robust reporter gene assay for measuring the bioactivity of OX40‐targeted therapeutic antibodies
Meng Li, Lan Wang, Chuanfei Yu, et al.
Luminescence (2020) Vol. 36, Iss. 4, pp. 885-893
Closed Access | Times Cited: 2
Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients Kimberley L. KaufmanSwetlana MactierNicola J. Armstrong • Duthika MallawaaratchyScott N. ByrneLauren E. HayduValerie Jakrot • John F. ThompsonGraham J. MannRichard A. ScolyerRichard I. Christopherson
Kimberley L. Kaufman, Swetlana Mactier, Duthika M. Mallawaaratchy, et al.
(2014)
Closed Access
Page 1

Scroll to top